The company announced today that it completed the first cohort in its first-in-human phase 1 SAD/MAD study of AKG-100, which is an oxazolidinone class of antibiotic for treatment of pulmonary ...

What is the current share price of Academies Australasia Group Limited (AKG)? Academies Australasia Group Limited's (AKG) current share price is $0.11. This constitutes a price movement of 5% when ...

In an announcement on Tuesday, April 1, Akagera Medicines said it has completed early-stages of its preclinical trials of AKG-100, a new antibiotic drug in the oxazolidinone class, designed to treat ...

The study consists of single ascending dosing (SAD) and multiple ascending dosing (MAD) to establish the safety and pharmacokinetics of AKG-100 alone in single doses in healthy volunteers and ...